NCT04596930View on ClinicalTrials.gov

MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 22, 2021

Primary Completion Date

February 11, 2022

Study Completion Date

May 31, 2022

Conditions
Glioblastoma
Interventions
PROCEDURE

Laser ablation thermal therapy

The Visualase Thermal Therapy System is used to necrotize or coagulate soft tissue through interstitial irradiation under MRI guidance

Trial Locations (1)

Unknown

Radboud UMC, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT04596930 - MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma | Biotech Hunter | Biotech Hunter